MNtech Past Earnings Performance
Past criteria checks 0/6
MNtech's earnings have been declining at an average annual rate of -11.3%, while the Chemicals industry saw earnings growing at 12.4% annually. Revenues have been growing at an average rate of 17.3% per year.
Key information
-11.3%
Earnings growth rate
-11.1%
EPS growth rate
Chemicals Industry Growth | 13.9% |
Revenue growth rate | 17.3% |
Return on equity | 0.3% |
Net Margin | -0.2% |
Last Earnings Update | 31 Dec 2023 |
Recent past performance updates
Recent updates
What You Can Learn From MNtech Co., Ltd.'s (KOSDAQ:095500) P/SAfter Its 27% Share Price Crash
Apr 17MNtech Co., Ltd. (KOSDAQ:095500) Stock Rockets 60% But Many Are Still Ignoring The Company
Feb 28Here's Why We Think MNtech (KOSDAQ:095500) Is Well Worth Watching
May 09We Like These Underlying Return On Capital Trends At MNtech (KOSDAQ:095500)
Apr 12We Think MNtech (KOSDAQ:095500) Can Stay On Top Of Its Debt
Mar 15We're Not Counting On MNtech (KOSDAQ:095500) To Sustain Its Statutory Profitability
Feb 08MNtech (KOSDAQ:095500) Share Prices Have Dropped 33% In The Last Five Years
Jan 10We Like These Underlying Trends At MNtech (KOSDAQ:095500)
Dec 13Revenue & Expenses BreakdownBeta
How MNtech makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
---|---|---|---|---|
31 Dec 23 | 694,026 | -1,214 | 38,398 | 8,336 |
30 Sep 23 | 617,668 | -254 | 39,871 | 6,614 |
30 Jun 23 | 569,746 | -9,208 | 40,554 | 6,614 |
31 Mar 23 | 526,857 | -13,601 | 38,918 | 6,813 |
31 Dec 22 | 490,328 | -7,901 | 39,091 | 6,614 |
30 Sep 22 | 482,275 | -5,666 | 41,976 | 7,079 |
30 Jun 22 | 470,394 | 9,064 | 41,327 | 7,079 |
31 Mar 22 | 463,727 | 21,432 | 39,887 | 8,651 |
31 Dec 21 | 458,244 | 22,242 | 40,234 | 7,079 |
30 Sep 21 | 466,721 | 37,000 | 35,439 | 7,159 |
30 Jun 21 | 470,275 | 37,156 | 33,858 | 7,159 |
31 Mar 21 | 437,530 | 30,536 | 32,011 | 7,159 |
31 Dec 20 | 403,599 | 21,361 | 34,308 | 7,159 |
30 Sep 20 | 367,063 | 8,434 | 30,078 | 8,564 |
30 Jun 20 | 322,517 | -1,423 | 29,270 | 8,564 |
31 Mar 20 | 306,958 | 802 | 27,763 | 8,564 |
31 Dec 19 | 293,033 | 840 | 26,594 | 8,564 |
30 Sep 19 | 285,229 | -5,603 | 29,980 | 6,797 |
30 Jun 19 | 286,144 | 5,768 | 29,564 | 6,797 |
31 Mar 19 | 284,972 | 1,137 | 29,347 | 6,797 |
31 Dec 18 | 278,109 | 6,072 | 27,365 | 6,797 |
30 Sep 18 | 264,394 | 6,862 | 24,999 | 8,195 |
30 Jun 18 | 263,564 | 2,663 | 25,460 | 8,195 |
31 Mar 18 | 260,395 | 10,882 | 25,897 | 8,195 |
31 Dec 17 | 280,596 | 9,916 | 28,251 | 8,195 |
30 Sep 17 | 290,201 | 4,694 | 30,923 | 9,541 |
30 Jun 17 | 311,738 | 7,951 | 32,157 | 9,541 |
31 Mar 17 | 327,669 | 6,068 | 33,423 | 9,541 |
31 Dec 16 | 314,545 | 1,032 | 33,829 | 9,541 |
30 Sep 16 | 293,285 | 14,713 | 34,563 | 9,466 |
30 Jun 16 | 263,784 | 3,012 | 33,569 | 9,466 |
31 Mar 16 | 244,442 | 963 | 32,540 | 9,466 |
31 Dec 15 | 233,142 | 622 | 32,731 | 9,466 |
30 Sep 15 | 236,895 | -20,665 | 26,236 | 12,293 |
30 Jun 15 | 231,012 | -23,984 | 28,541 | 12,293 |
31 Mar 15 | 234,744 | -35,143 | 30,123 | 12,293 |
31 Dec 14 | 223,070 | -39,804 | 30,461 | 12,293 |
30 Sep 14 | 238,185 | -31,894 | 33,726 | 9,565 |
30 Jun 14 | 246,930 | -30,078 | 33,069 | 9,565 |
31 Mar 14 | 258,292 | -13,376 | 32,546 | 9,565 |
31 Dec 13 | 278,883 | -2,612 | 30,420 | 9,565 |
30 Sep 13 | 300,128 | 12,591 | 35,470 | 9,718 |
30 Jun 13 | 320,741 | 24,857 | 34,840 | 9,718 |
Quality Earnings: A095500 is currently unprofitable.
Growing Profit Margin: A095500 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: A095500 is unprofitable, and losses have increased over the past 5 years at a rate of 11.3% per year.
Accelerating Growth: Unable to compare A095500's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: A095500 is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (-14.1%).
Return on Equity
High ROE: A095500 has a negative Return on Equity (0.3%), as it is currently unprofitable.